_id
691724603c536f8df2316a41
Ticker
TVGN
Name
Tevogen Bio Holdings Inc
Exchange
NASDAQ
Address
15 Independence Boulevard, Warren, NJ, United States, 07059
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://tevogen.com
Description
Tevogen Bio Holdings Inc., a clinical-stage specialty immunotherapy company, develops off-the-shelf precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders. The company develops TVGN 489, which has completed Phase 1 clinical trial for the treatment of ambulatory high-risk adult COVID-19 patients; and in phase 1 clinical trial to treat acute SARS-CoV-2 patients with B-cell cancer immune suppression, and other B cell immune suppressed acute SARS-CoV-2 patients with a B cell cancer indication, as well as Long COVID prevention and treatment. It is also developing TVGN 920 which is in preclinical trial for treating cervical cancer; TVGN 960 which is in preclinical trial for treating oropharyngeal cancer; TVGN 601 which is in preclinical trial for treating multiple sclerosis; TVGN 930 which is in preclinical trial for treating Epstein-Barr virus associated lymphomas; and TVGN 116 a product candidate targeted at hepatitis B and is in preclinical trial. Tevogen Bio Holdings Inc. was formerly known as Tevogen Bio Inc. and changed its name to Tevogen Bio Holdings Inc. in February 2024. The company was founded in 2020 and is headquartered in Warren, New Jersey.
Last Close
0.364
Volume
463873
Current Price
0.3242
Change
-0.0099
Last Updated
2026-01-07T13:39:44.584Z
Image
https://logo.clearbit.com/tevogen.com
Ipo Date
2024-02-15T00:00:00.000Z
Market Cap
69362648
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.984
Sentiment Sources
2
Rating
5
Target Price
5
Strong Buy
1
Buy
0
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
27225
Gross Profit
-27225
Operating Expenses
5702206
Operating Income
-5729431
Interest Expense
62340
Pretax Income
-5726812
Net Income
-5726812
Eps
-0.029214138266551712
Dividends Per Share
-
Shares Outstanding
198689921
Income Tax Expense
-
EBITDA
-5637247
Operating Margin
-
Total Other Income Expense Net
2619
Cash
1037094
Short Term Investments
-
Receivables
158819
Inventories
-
Total Current Assets
2121734
Property Plant Equipment
1615128
Total Assets
4493669
Payables
3311931
Short Term Debt
1978740
Long Term Debt
4400000
Total Liabilities
12317565
Equity
-7823896
Bs_currency_symbol
USD
Depreciation
27225
Change In Working Capital
-1129915
Cash From Operations
-3649544
Capital Expenditures
4
Cash From Investing
-
Cash From Financing
4001409
Net Change In Cash
351865
Cf_currency_symbol
USD
PE
-
PB
-8.122875326154643
ROE
73.19642285633654
ROA
-127.44178532063665
FCF
-3649548
Fcf Percent
-
Piotroski FScore
1
Health Score
39
Deep Value Investing Score
0.5
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
5.3
Garp Investing Score
2
Growth Investing Score
2
Momentum Investing Score
2
Net Net Investing Score
0.5
Quality Investing Score
2.5
Value Investing Score
2.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
27225
Quarters > 0 > income Statement > gross Profit
-27225
Quarters > 0 > income Statement > operating Expenses
5702206
Quarters > 0 > income Statement > operating Income
-5729431
Quarters > 0 > income Statement > interest Expense
62340
Quarters > 0 > income Statement > pretax Income
-5726812
Quarters > 0 > income Statement > net Income
-5726812
Quarters > 0 > income Statement > eps
-0.029214138266551712
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
196028784
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-5637247
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
2619
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
1037094
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
158819
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
2121734
Quarters > 0 > balance Sheet > property Plant Equipment
1615128
Quarters > 0 > balance Sheet > total Assets
4493669
Quarters > 0 > balance Sheet > payables
3311931
Quarters > 0 > balance Sheet > short Term Debt
1978740
Quarters > 0 > balance Sheet > long Term Debt
4400000
Quarters > 0 > balance Sheet > total Liabilities
12317565
Quarters > 0 > balance Sheet > equity
-7823896
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-5726812
Quarters > 0 > cash Flow > depreciation
27225
Quarters > 0 > cash Flow > change In Working Capital
-1129915
Quarters > 0 > cash Flow > cash From Operations
-3649544
Quarters > 0 > cash Flow > capital Expenditures
4
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
4001409
Quarters > 0 > cash Flow > net Change In Cash
351865
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.029214138266551712
Quarters > 0 > ratios > PB
-8.122875326154643
Quarters > 0 > ratios > ROE
73.19642285633654
Quarters > 0 > ratios > ROA
-127.44178532063665
Quarters > 0 > ratios > FCF
-3649548
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
39
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
290784
Quarters > 1 > income Statement > gross Profit
-290784
Quarters > 1 > income Statement > operating Expenses
5153752
Quarters > 1 > income Statement > operating Income
-5444536
Quarters > 1 > income Statement > interest Expense
38033
Quarters > 1 > income Statement > pretax Income
-5503979
Quarters > 1 > income Statement > net Income
-5503979
Quarters > 1 > income Statement > eps
-0.02986307602608773
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
184307169
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-5175162
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-59443
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
685229
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
158819
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
2060899
Quarters > 1 > balance Sheet > property Plant Equipment
1642353
Quarters > 1 > balance Sheet > total Assets
4269136
Quarters > 1 > balance Sheet > payables
4240302
Quarters > 1 > balance Sheet > short Term Debt
1978740
Quarters > 1 > balance Sheet > long Term Debt
4400000
Quarters > 1 > balance Sheet > total Liabilities
13753878
Quarters > 1 > balance Sheet > equity
-9484742
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-5503979
Quarters > 1 > cash Flow > depreciation
26592
Quarters > 1 > cash Flow > change In Working Capital
-1212674
Quarters > 1 > cash Flow > cash From Operations
-3189703
Quarters > 1 > cash Flow > capital Expenditures
3
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
1900000
Quarters > 1 > cash Flow > net Change In Cash
-1289703
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.02986307602608773
Quarters > 1 > ratios > PB
-6.299842862336161
Quarters > 1 > ratios > ROE
58.02982305686333
Quarters > 1 > ratios > ROA
-128.92489253094772
Quarters > 1 > ratios > FCF
-3189706
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
39
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
396586
Quarters > 2 > income Statement > cost Of Revenue
105402
Quarters > 2 > income Statement > gross Profit
-105402
Quarters > 2 > income Statement > operating Expenses
10250945
Quarters > 2 > income Statement > operating Income
-10356347
Quarters > 2 > income Statement > interest Expense
24571
Quarters > 2 > income Statement > pretax Income
-10367061
Quarters > 2 > income Statement > net Income
-10367061
Quarters > 2 > income Statement > eps
-0.06422926576790543
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
161407123
Quarters > 2 > income Statement > income Tax Expense
60000
Quarters > 2 > income Statement > EBITDA
-10237088
Quarters > 2 > income Statement > operating Margin
-2611.374834209982
Quarters > 2 > income Statement > total Other Income Expense Net
-10714
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
1974932
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
158819
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
3077807
Quarters > 2 > balance Sheet > property Plant Equipment
419530
Quarters > 2 > balance Sheet > total Assets
4073178
Quarters > 2 > balance Sheet > payables
4664746
Quarters > 2 > balance Sheet > short Term Debt
1821851
Quarters > 2 > balance Sheet > long Term Debt
3000000
Quarters > 2 > balance Sheet > total Liabilities
11793274
Quarters > 2 > balance Sheet > equity
-7720096
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-10367061
Quarters > 2 > cash Flow > depreciation
105402
Quarters > 2 > cash Flow > change In Working Capital
-349825
Quarters > 2 > cash Flow > cash From Operations
-3308063
Quarters > 2 > cash Flow > capital Expenditures
3
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
4000000
Quarters > 2 > cash Flow > net Change In Cash
691937
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.06422926576790543
Quarters > 2 > ratios > PB
-6.778178571432273
Quarters > 2 > ratios > ROE
134.286685036041
Quarters > 2 > ratios > ROA
-254.52020510765797
Quarters > 2 > ratios > FCF
-3308066
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-8.341358494752715
Quarters > 2 > health Score
31
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
9423210
Quarters > 3 > income Statement > operating Income
-9423210
Quarters > 3 > income Statement > interest Expense
15798
Quarters > 3 > income Statement > pretax Income
-9504552
Quarters > 3 > income Statement > net Income
-9444552
Quarters > 3 > income Statement > eps
-0.05306185499504428
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
177991365
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-65544
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
1282995
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
2360902
Quarters > 3 > balance Sheet > property Plant Equipment
524932
Quarters > 3 > balance Sheet > total Assets
3461675
Quarters > 3 > balance Sheet > payables
5200245
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
1000000
Quarters > 3 > balance Sheet > total Liabilities
10135680
Quarters > 3 > balance Sheet > equity
-6674005
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-9444552
Quarters > 3 > cash Flow > depreciation
103547
Quarters > 3 > cash Flow > change In Working Capital
-749045
Quarters > 3 > cash Flow > cash From Operations
-3047686
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
2000000
Quarters > 3 > cash Flow > net Change In Cash
-1047686
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.05306185499504428
Quarters > 3 > ratios > PB
-8.646202772248447
Quarters > 3 > ratios > ROE
141.51251010450247
Quarters > 3 > ratios > ROA
-272.831851632519
Quarters > 3 > ratios > FCF
-3047686
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
39
Annuals > 0 > quarter
2025-06-30
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
403581
Annuals > 0 > income Statement > gross Profit
-403581
Annuals > 0 > income Statement > operating Expenses
53160907
Annuals > 0 > income Statement > operating Income
-53564488
Annuals > 0 > income Statement > interest Expense
184037
Annuals > 0 > income Statement > pretax Income
-13727380
Annuals > 0 > income Statement > net Income
-10114380
Annuals > 0 > income Statement > eps
-0.06895892314780626
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
146672534
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-13139762
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
39837108
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
1282995
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
158819
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
2360902
Annuals > 0 > balance Sheet > property Plant Equipment
524932
Annuals > 0 > balance Sheet > total Assets
3461675
Annuals > 0 > balance Sheet > payables
5200245
Annuals > 0 > balance Sheet > short Term Debt
1880063
Annuals > 0 > balance Sheet > long Term Debt
1000000
Annuals > 0 > balance Sheet > total Liabilities
10135680
Annuals > 0 > balance Sheet > equity
-6674005
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-13727380
Annuals > 0 > cash Flow > depreciation
403581
Annuals > 0 > cash Flow > change In Working Capital
-5487
Annuals > 0 > cash Flow > cash From Operations
-11998730
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
12229328
Annuals > 0 > cash Flow > net Change In Cash
230598
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-0.06895892314780626
Annuals > 0 > ratios > PB
-7.672062220420872
Annuals > 0 > ratios > ROE
151.5488825675138
Annuals > 0 > ratios > ROA
-292.18167505615054
Annuals > 0 > ratios > FCF
-11998730
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
31
Annuals > 1 > quarter
2024-06-30
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
378357
Annuals > 1 > income Statement > gross Profit
-378357
Annuals > 1 > income Statement > operating Expenses
8464668
Annuals > 1 > income Statement > operating Income
-8843025
Annuals > 1 > income Statement > interest Expense
256031
Annuals > 1 > income Statement > pretax Income
-60477680
Annuals > 1 > income Statement > net Income
-60477680
Annuals > 1 > income Statement > eps
-0.3655983780157069
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
165421084
Annuals > 1 > income Statement > income Tax Expense
255867
Annuals > 1 > income Statement > EBITDA
-58892971
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-51634655
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
1052397
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
344500
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
1722979
Annuals > 1 > balance Sheet > property Plant Equipment
928513
Annuals > 1 > balance Sheet > total Assets
5505503
Annuals > 1 > balance Sheet > payables
3418378
Annuals > 1 > balance Sheet > short Term Debt
80964714
Annuals > 1 > balance Sheet > long Term Debt
14220000
Annuals > 1 > balance Sheet > total Liabilities
99934400
Annuals > 1 > balance Sheet > equity
-94428897
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-60477680
Annuals > 1 > cash Flow > depreciation
378357
Annuals > 1 > cash Flow > change In Working Capital
293205
Annuals > 1 > cash Flow > cash From Operations
-8171118
Annuals > 1 > cash Flow > capital Expenditures
133000
Annuals > 1 > cash Flow > cash From Investing
-133000
Annuals > 1 > cash Flow > cash From Financing
3872250
Annuals > 1 > cash Flow > net Change In Cash
-4431868
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.3655983780157069
Annuals > 1 > ratios > PB
-0.6115553846234167
Annuals > 1 > ratios > ROE
64.04573379693295
Annuals > 1 > ratios > ROA
-1098.4950875514917
Annuals > 1 > ratios > FCF
-8304118
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
31
Annuals > 2 > quarter
2023-06-30
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
-
Annuals > 2 > income Statement > operating Expenses
953083
Annuals > 2 > income Statement > operating Income
-953083
Annuals > 2 > income Statement > interest Expense
0
Annuals > 2 > income Statement > pretax Income
4408361
Annuals > 2 > income Statement > net Income
4408361
Annuals > 2 > income Statement > eps
0.03673634503416496
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
119999989
Annuals > 2 > income Statement > income Tax Expense
-230823
Annuals > 2 > income Statement > EBITDA
4408361
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
5361444
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
5484265
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
5837242
Annuals > 2 > balance Sheet > property Plant Equipment
1306870
Annuals > 2 > balance Sheet > total Assets
7738995
Annuals > 2 > balance Sheet > payables
865910
Annuals > 2 > balance Sheet > short Term Debt
278207
Annuals > 2 > balance Sheet > long Term Debt
39297000
Annuals > 2 > balance Sheet > total Liabilities
41690212
Annuals > 2 > balance Sheet > equity
-33951217
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-22041401
Annuals > 2 > cash Flow > depreciation
230823
Annuals > 2 > cash Flow > change In Working Capital
-96922
Annuals > 2 > cash Flow > cash From Operations
-8655855
Annuals > 2 > cash Flow > capital Expenditures
479042
Annuals > 2 > cash Flow > cash From Investing
-479042
Annuals > 2 > cash Flow > cash From Financing
7500000
Annuals > 2 > cash Flow > net Change In Cash
-1634897
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
0.03673634503416496
Annuals > 2 > ratios > PB
-1.2338879092287032
Annuals > 2 > ratios > ROE
-12.984397584334017
Annuals > 2 > ratios > ROA
56.96296482941261
Annuals > 2 > ratios > FCF
-9134897
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
39
Annuals > 3 > quarter
2022-06-30
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
4618462
Annuals > 3 > income Statement > operating Income
-4618462
Annuals > 3 > income Statement > interest Expense
598502
Annuals > 3 > income Statement > pretax Income
-15596798
Annuals > 3 > income Statement > net Income
-15596798
Annuals > 3 > income Statement > eps
-0.32538521783995283
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
47933333
Annuals > 3 > income Statement > income Tax Expense
-9781332
Annuals > 3 > income Statement > EBITDA
-14988919
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-10978336
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
7119162
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
7173125
Annuals > 3 > balance Sheet > property Plant Equipment
142623
Annuals > 3 > balance Sheet > total Assets
7658396
Annuals > 3 > balance Sheet > payables
377997
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
23479000
Annuals > 3 > balance Sheet > total Liabilities
24146944
Annuals > 3 > balance Sheet > equity
-16488548
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-15596798
Annuals > 3 > cash Flow > depreciation
9377
Annuals > 3 > cash Flow > change In Working Capital
-1248936
Annuals > 3 > cash Flow > cash From Operations
-5274949
Annuals > 3 > cash Flow > capital Expenditures
109727
Annuals > 3 > cash Flow > cash From Investing
-109727
Annuals > 3 > cash Flow > cash From Financing
12500000
Annuals > 3 > cash Flow > net Change In Cash
7115324
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.32538521783995283
Annuals > 3 > ratios > PB
-1.0148574968699489
Annuals > 3 > ratios > ROE
94.59170085807435
Annuals > 3 > ratios > ROA
-203.65619641501956
Annuals > 3 > ratios > FCF
-5384676
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
31
Valuation > metrics > PE
-0.029214138266551712
Valuation > metrics > PB
-8.122875326154643
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
73.19642285633654
Profitability > metrics > ROA
-269.91187396723626
Profitability > final Score
55
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-91.90617581007379
Risk > final Score
-338
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.40103306366999575
Liquidity > metrics > Quick Ratio
0.40103306366999575
Liquidity > final Score
30
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
55
Prev Profitabilities > 1
40
Prev Profitabilities > 2
55
Prev Risks > 0
-543
Prev Risks > 1
-1656
Prev Risks > 2
-2356
Prev Liquidities > 0
27
Prev Liquidities > 1
34
Prev Liquidities > 2
33
Updated At
2026-01-20T22:44:19.912Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-31
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-0.03
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-14
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
BeforeMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.03
Earnings History > 1 > eps Estimate
-0.06
Earnings History > 1 > eps Difference
0.03
Earnings History > 1 > surprise Percent
50
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-14
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.03
Earnings History > 2 > eps Estimate
-0.05
Earnings History > 2 > eps Difference
0.02
Earnings History > 2 > surprise Percent
40
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-14
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.07
Earnings History > 3 > eps Estimate
-0.05
Earnings History > 3 > eps Difference
-0.02
Earnings History > 3 > surprise Percent
-40
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2024-12-31
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-0.052
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-09-30
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.0347
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-14
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.0394
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-27
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.2602
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2023-12-31
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.0555
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-09-30
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.0176
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-06-30
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.0123
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-04-17
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
0.05
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2022-12-31
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
0.0545
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-11-14
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
0.03
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-15
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
0.0043
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-04-01
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.0005
Earnings History > 15 > eps Estimate
-
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-05
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
-
Earnings History > 16 > eps Actual
0
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Tevogen Bio Holdings Inc., a clinical-stage specialty immunotherapy company, develops off-the-shelf precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders. The company develops TVGN 489, which has completed Phase 1 clinical trial for the treatment of ambulatory high-risk adult COVID-19 patients; and in phase 1 clinical trial to treat acute SARS-CoV-2 patients with B-cell cancer immune suppression, and other B cell immune suppressed acute SARS-CoV-2 patients with a B cell cancer indication, as well as Long COVID prevention and treatment. It is also developing TVGN 920 which is in preclinical trial for treating cervical cancer; TVGN 960 which is in preclinical trial for treating oropharyngeal cancer; TVGN 601 which is in preclinical trial for treating multiple sclerosis; TVGN 930 which is in preclinical trial for treating Epstein-Barr virus associated lymphomas; and TVGN 116 a product candidate targeted at hepatitis B and is in preclinical trial. Tevogen Bio Holdings Inc. was formerly known as Tevogen Bio Inc. and changed its name to Tevogen Bio Holdings Inc. in February 2024. The company was founded in 2020 and is headquartered in Warren, New Jersey.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ACan RDIB be the next market leader - Portfolio Performance Summary & Accurate Intraday Trading Signals bollywoodhelpline.com
Read more →Gains Recap: What dividend safety score for TVGN stock - Portfolio Profit Report & Fast Entry and Exit Trade Plans Bộ Nội Vụ
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$5
Analyst Picks
Strong Buy
1
Buy
0
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
* Institutions hold a combined 0.00% of the total shares of Tevogen Bio Holdings Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-0.03
Date
2025-09-30
EPS Actual
-0.03
EPS Estimate
-0.06
EPS Difference
0.03
Surprise Percent
50%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.